BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28532265)

  • 21. Bifrontal encephalogaleosynangiosis for children with moyamoya disease.
    Ogiwara H; Morota N
    J Neurosurg Pediatr; 2012 Sep; 10(3):246-51. PubMed ID: 22816605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative evaluation of moyamoya disease with perfusion-weighted MR imaging: initial experience.
    Lee SK; Kim DI; Jeong EK; Kim SY; Kim SH; In YK; Kim DS; Choi JU
    AJNR Am J Neuroradiol; 2003 Apr; 24(4):741-7. PubMed ID: 12695215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of a cerebral pial arteriovenous fistula in a patient with sickle cell disease-related moyamoya syndrome: case report.
    Lo Presti A; Weil AG; Fallah A; Peterson EC; Niazi TN; Bhatia S
    J Neurosurg Pediatr; 2015 Aug; 16(2):207-11. PubMed ID: 26053963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Outcomes After Encephaloduroarteriosynangiosis in Adult Patients with Moyamoya Disease Presenting with Ischemia.
    Bao XY; Zhang Y; Wang QN; Zhang Q; Wang H; Zhang ZS; Li DS; Duan L
    World Neurosurg; 2018 Jul; 115():e482-e489. PubMed ID: 29684518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative angiographic comparison with the OSIRIS program between the direct and indirect revascularization modalities in adult moyamoya disease.
    Bang JS; Kwon OK; Kim JE; Kang HS; Park H; Cho SY; Oh CW
    Neurosurgery; 2012 Mar; 70(3):625-32; discussion 632-3. PubMed ID: 21866061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal) synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT.
    Song YS; Oh SW; Kim YK; Kim SK; Wang KC; Lee DS
    Ann Nucl Med; 2012 Jan; 26(1):47-57. PubMed ID: 22033781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study.
    Aldana PR; Hanel RA; Piatt J; Han SH; Bansal MM; Schultz C; Gauger C; Pederson JM; Iii JCW; Hulbert ML; Jordan LC; Qureshi A; Garrity K; Robert AP; Hatem A; Stein J; Beydler E; Adelson PD; Greene S; Grabb P; Johnston J; Lang SS; Leonard J; Magge SN; Scott A; Shah S; Smith ER; Smith J; Strahle J; Vadivelu S; Webb J; Wrubel D
    Pediatr Blood Cancer; 2023 Jul; 70(7):e30336. PubMed ID: 37057741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moya Moya cases treated with encephaloduroarteriosynangiosis.
    Tripathi P; Tripathi V; Naik RJ; Patel JM
    Indian Pediatr; 2007 Feb; 44(2):123-7. PubMed ID: 17351302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term outcomes after conservative and EDAS treatment for 111 elderly patients with moyamoya disease: longitudinal and cross-sectional study.
    Li JJ; Wang XP; Wang QN; Bao XY; Guo QB; Kong ZQ; Gao G; Wang MJ; Liu SM; Fu HG; Zhang Q; Duan L
    J Neurosurg; 2024 Mar; 140(3):800-808. PubMed ID: 37724788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omental transplantation using a superficial temporal artery previously used for encephaloduroarteriosynangiosis.
    Touho H; Karasawa J; Tenjin H; Ueda S
    Surg Neurol; 1996 Jun; 45(6):550-8; discussion 558-9. PubMed ID: 8638241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anatomic Variation of the Superficial Temporal Artery and Posterior Auricular Artery in a Pediatric Moyamoya Disease Population.
    Lee S; Kim SK; Phi JH
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1157-1162. PubMed ID: 33737264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiographic revascularization of the brain after encephaloduroarteriosynangiosis: a case report.
    Matsushima Y; Suzuki R; Ohno K; Masaoka H; Wakabayashi S; Maehara T
    Neurosurgery; 1987 Dec; 21(6):928-34. PubMed ID: 3325852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in cerebral hemodynamics following encephalo-duro-arterio-synangiosis (EDAS) in young patients with moyamoya disease.
    Suzuki R; Matsushima Y; Takada Y; Nariai T; Wakabayashi S; Tone O
    Surg Neurol; 1989 May; 31(5):343-9. PubMed ID: 2711307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bilateral encephaloduroarteriosynangiosis (EDAS) in a 6-year-old female for moyamoya disease: case report and technical note with 12-year follow-up.
    Dapaah A; Barone D; May P
    Childs Nerv Syst; 2016 Apr; 32(4):745-7. PubMed ID: 26285762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encephaloduroarteriosynangiosis Procedure: A Treatment Option for Patients With Moyamoya Disease.
    Karasin B; Boyce M; Kleban M; Hancock J; Rizzo G; Hardinge T; Eskuchen L; Watkinson J; Gold E
    AORN J; 2024 Mar; 119(3):198-209. PubMed ID: 38407362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the Posterior Auricular Artery for Indirect Bypass in Moyamoya: A Pediatric Case Series.
    Hawkins JC; Ryan MV; Graber S; Neuberger I; Slade J; Young M; Maloney JA; Wilkinson CC
    Pediatr Neurosurg; 2023; 58(2):105-113. PubMed ID: 36809759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracranial Aneurysms in Sickle-Cell Disease Are Associated With the Hemoglobin SS Genotype But Not With Moyamoya Syndrome.
    Birkeland P; Gardner K; Kesse-Adu R; Davies J; Lauritsen J; Rom Poulsen F; Tolias CM; Thein SL
    Stroke; 2016 Jul; 47(7):1710-3. PubMed ID: 27301940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events.
    Dobson SR; Holden KR; Nietert PJ; Cure JK; Laver JH; Disco D; Abboud MR
    Blood; 2002 May; 99(9):3144-50. PubMed ID: 11964276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.